Highlights and Quick Summary
- Annual ROE for 2022 was 24.24% (a -122.95% decrease from previous year)
- Annual ROE for 2021 was -105.62% (a -56.99% decrease from previous year)
- Annual ROE for 2020 was -245.56% (a 71.58% increase from previous year)
- Twelve month ROE ending December 31, 2022 was -56.83% (a 12.36% increase compared to previous quarter)
- Twelve month trailing ROE decreased by -24.92% year-over-year
Trailing ROE for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -56.83% | -50.58% | -85.35% | -75.69% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROE of Precigen, Inc.
Most recent ROEof PGEN including historical data for past 10 years.Interactive Chart of ROE of Precigen, Inc.
Precigen, Inc. ROE for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | – | – | 24.24% |
| 2021 | – | – | – | – | -105.62% |
| 2020 | – | – | – | – | -245.56% |
| 2019 | – | – | – | – | -143.12% |
| 2018 | – | – | – | – | -110.09% |
| 2017 | – | – | – | – | -20.97% |
| 2016 | – | – | – | – | -29.29% |
| 2015 | – | – | – | – | -15.17% |
| 2014 | – | – | – | – | -20.7% |
| 2013 | – | – | – | – | -191.91% |
| 2012 | – | – | – | – | 38.27% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology